Welcome And The Diet War Problem

Nicolette 0:00

Welcome to the Health Pulse, your go-to source for quick, actionable insights on health, wellness, and diagnostics. Whether you're looking to optimize your well-being or stay informed about the latest in-medical testing, we've got you covered. Join us as we break down key health topics in just minutes. Let's dive in.

Rachel 0:24

You know, it seems like every single time you open up a web browser or like turn on the news, there is a totally new frontline in these endless exhausting diet wars.

Mark 0:35

Oh, it is exhausting. I mean it really is.

Rachel 0:38

Right. Like one day you are supposed to eat nothing but steak and butter. And then literally the very next day, a new documentary comes out telling you that you should be eating strictly plants and absolutely zero fat.

Mark 0:50

Yeah, the whipplash is real.

Rachel 0:51

It totally is. And the most frustrating part of all this for you, as someone's trying to sort through the noise, is that you look at people doing both of these extreme diets, and well, if they lose weight, they both seem to get healthier.

Mark 1:03

They do. Yeah. Which is exactly what makes it so confusing for few people.

Rachel 1:07

Exactly. It makes you wonder, does this actually matter what you eat? As long as you shed in the pounds. It's like, are the macronutrients, you know, but the carbs, fats, the proteins, are they just a distraction from the simple thermodynamics of weight loss?

Mark 1:19

I mean, that is the ultimate nutritional frustration. You have this deep, deep desire to find the optimal metabolic fuel for the human body. But the reality of weight loss always seems to just kind of muddy the waters.

Rachel 1:32

How so?

Mark 1:33

Well, when someone loses a significant amount of adipose tissue, so fat tissue, a whole cascade of physiological markers automatically improves across the board.

Rachel 1:43

Right, just from losing the weight itself.

Mark 1:45

Exactly. And that masks the specific metabolic effects of the macronutrients themselves. It makes it nearly impossible to see what the food is actually doing.

Rachel 1:53

And that is exactly the mission of our deep dive today. We are going to finally separate the metabolic effects of weight loss from the actual macronutrients that we consume.

Mark 2:03

Yes, which is a massive undertaking.

Rachel 2:05

It really is. And to do this, we are drawing on a detailed breakdown by Quick Lab Mobile. They recently analyzed a highly rigorous randomized controlled feeding trial published in the journal Cell Metabolism.

Mark 2:16

A fantastic journal, by the way. Very high standards.

Rachel 2:19

Yeah. And the way they designed the study provides some serious clarity on tissue-specific insulin resistance.

Mark 2:26

Okay, let's unpack

Why Most Diet Studies Mislead

Mark 2:27

this. Because to understand why the study is so critical, we really first have to address the inherent structural flaws in almost every other longitudinal nutrition study out there.

Rachel 2:37

Oh, absolutely. I mean, the standard epidemiological approach to nutrition science is built on a very, very shaky foundation.

Mark 2:44

Which is self-reporting.

Rachel 2:45

Right, self-reporting. Researchers will give a cohort of participants a set of dietary parameters, send them out into the real world, and rely on food frequency questionnaires or like daily food diaries to track compliance.

Mark 2:57

Which fundamentally ignores human behavior. I mean, let's be real.

Rachel 3:00

Oh, completely.

Mark 3:01

Yeah.

Rachel 3:02

Even with the absolute best intentions, people notoriously underestimate their caloric intake.

Mark 3:07

Yeah, they forget the handful of nuts they grabbed at 2 p.m.

Rachel 3:10

Exactly. They omit random grazing throughout the day, and they simply deviate from their assigned macros when life gets stressful.

Mark 3:16

Because life happens. And then you end up with a data set full of noise rather than a clear picture of any actual biological mechanism. The uncertainty in those studies is massive. But see, this trial in cell metabolism completely engineered that variable out of existence.

Three Diets With Matched Weight Loss

Rachel 3:33

They didn't just ask them what they ate.

Mark 3:34

No, they didn't rely on self-reporting at all. They physically provided the meals for 42 adults.

unknown 3:40

Wow.

Rachel 3:41

Every single meal.

Mark 3:43

Every single meal. And they selected a very specific cohort. They looked at adults presenting with obesity, prediabetes, and fatty liver.

Rachel 3:51

Okay, so they were looking at a population already demonstrating the interconnected hallmarks of metabolic dysfunction.

Mark 3:56

Exactly. These were people who are already metabolically compromised.

Rachel 3:59

So they took these 42 adults and then randomly split them into three distinct dietary interventions.

Mark 4:05

They did. The first was a very low carbohydrate ketogenic diet. We're talking about 4% carbohydrates and a massive 73% fat.

Rachel 4:13

That is a lot of fat.

Mark 4:14

It is a lot. The second was a Mediterranean diet sitting at about 50% carbs and 35% fat.

Rachel 4:20

Aaron Powell Sort of the gold standard balance diet.

Mark 4:22

Aaron Powell Right. And the third was a very low-fat plant-forward diet. This was almost the inverse of keto, at roughly 70% carbs and only 15% fat.

Rachel 4:33

Aaron Powell Okay, so three wildly different approaches to fueling the body.

Mark 4:36

Aaron Powell Wildly different. But what's fascinating here is that the researchers introduced a highly controlled variable that acts as a total game changer for nutrition science.

Rachel 4:46

I know what you're going to say, and it's brilliant.

Mark 4:48

They continuously adjusted the daily caloric provision for every single participant throughout the trial.

Rachel 4:55

So if someone was losing weight too fast, they gave them more food.

Mark 4:58

Exactly. They modulated the calories to ensure that everyone across all three groups lost the exact same amount of weight.

Rachel 5:05

Which was about 10% of their initial body mass.

Mark 5:08

Right, approximately 10%.

Rachel 5:10

It's like testing three completely different types of car fuel, but meticulously modulating the throttle so all three cars drive exactly 100 miles on the dot. We are not testing the distance they can travel. We're opening up the hood to test the specific wear and tear on the engine after the exact same trip.

Mark 5:27

That is a perfect analogy. That 10% matching isolates the macronutrient composition from the confounding variable of weight loss.

Rachel 5:36

Because people always argue about that with keto, right?

Mark 5:38

Oh, constantly. Critics of low carbohydrate diets often argue that the observed metabolic benefits are purely the result of spontaneous caloric restriction.

Rachel 5:47

Like you just eat less because you're full from all the fat and protein.

Mark 5:51

Exactly. The argument is that protein and fat increase satiety, leading to greater weight loss, and the weight loss itself drives the health improvements, not the absence of carbohydrates.

Rachel 6:03

But the study design neutralizes that argument entirely.

Mark 6:06

Completely neutralizes it. Everyone lost 10%, period.

Rachel 6:10

So if the weight loss is identical, what is actually happening at the tissue level? Because skeletal muscle and the liver process fuel very differently. And this study looked at both of those. Let's start

Muscle Improves Regardless Of Macros

Rachel 6:19

with the muscles.

Mark 6:19

Okay, so skeletal muscle acts as the primary glucose sink for the body in the postprandial state.

Rachel 6:24

Which just means after you eat.

Mark 6:26

Right, after a meal. When that tissue becomes insulin resistant, you basically lose your main avenue for clearing glucose from the bloodstream.

Rachel 6:34

Which leaves all that sugar just floating around in your blood.

Mark 6:36

Exactly. But in this trial, after achieving the 10% weight loss, participants across all three diets saw their skeletal muscle insulin sensitivity improve by approximately 50%.

Rachel 6:49

Wait, all three diets.

Mark 6:51

All three.

Rachel 6:52

Meaning the specific macronutrient ratio, whether it was 73% fat or 70% carbohydrates, didn't drastically alter the outcome for the muscle tissue.

Mark 7:01

It really didn't. Shedding the mass was the dominant biological lever there.

Rachel 7:05

So just dropping the weight fixed the muscles.

Mark 7:08

Yeah, the sheer act of reducing overall adiposity appears to be the overriding factor for restoring insulin signaling in skeletal muscle. It alleviates the lepotoxicity that interferes with the insulin receptor pathways in those muscle cells.

Rachel 7:20

Wait, so losing weight is basically a universal win for our muscles, but our liver is actually a picky eater.

Keto’s Liver Advantage

Mark 7:26

That is a very good way to put it, yes. The liver presented a completely divergent response in this study.

Rachel 7:31

How different are we talking?

Mark 7:32

Well, while all diets reduce liver fat to some degree, the ketogenic group achieved a 67% average reduction in intrahepatic lipid content.

Rachel 7:43

That's huge. What about the other diets?

Mark 7:46

The Mediterranean and plant forward groups hovered around 45%.

Rachel 7:49

Still good, but nowhere near the keto group.

Mark 7:51

Nowhere near. And furthermore, the keto diet improved hepatic or liver insulin sensitivity roughly two to three times more than the other diets.

Rachel 8:00

Two to three times more, despite losing the exact same amount of weight.

Mark 8:04

Exactly. The disparity is profound. And it really requires looking at the hormonal milieu the liver is exposed to under these different dietary conditions.

Rachel 8:13

Okay, let's get into the mechanics of that. Why does the liver care so much about the carbs if the calories are the same?

Mark 8:19

So the liver is the body's glucose factory during fasting. It uses processes called glycogenolysis and glyconeogenesis to maintain basal blood glucose levels.

Rachel 8:30

Basically making sure you don't pass out from low blood sugar when you haven't eaten in a few hours.

Mark 8:34

Right. However, in a state of hepatic insulin resistance, that signaling becomes severely dysregulated. The liver fails to recognize that blood glucose and insulin levels are already elevated. Yeah. So it just continues to synthesize and release even more glucose.

Rachel 8:51

So the normal feedback loop is totally broken. The liver keeps dumping fuel into the bloodstream even when the system is already completely saturated.

Mark 8:58

It does. And compounding the issue. While the liver is ignoring the signal to suppress hepatic glucose production, it remains highly sensitive to the insulin signal drive and needing novel lipogenesis.

Rachel 9:10

To novel lipogenesis, that's the conversion of X carbs into fat, right?

Mark 9:14

Exactly. It's turning those carbohydrates substrates into triglycotrides. So the liver is simultaneously overproducing glucose and hoarding fat. It's the worst of both worlds.

Rachel 9:22

Man, okay, here's where it gets really interesting. Because the ketogenic diet seems to target that specific dysfulation far more aggressively than simply losing weight on a plant forward diet. Meaning both groups lost 10% of their body weight. The keto group must have altered some kind of secondary pathway.

Mark 9:40

They did. They fundamentally shifted the glucocagon to insulin ratio.

Rachel 9:44

Which means what exactly?

Mark 9:46

By restricting carbohydrate to 4%, the keto group maintained much lower circulating insulin levels and much higher levels of a hormone called glucagon.

Rachel 9:54

And the liver listens to glucocagon.

Mark 9:56

Oh, and intensely. This specific endcriting environment signals the liver to completely halt that denovel epogenesis. It shuts down fat storage. Wow. And instead uregulates fatty acid oxidation. The liver begins aggressively exporting and burning its stored triglycerides, converting them into ketone bodies to fuel the brain and other tissues.

Rachel 10:20

It's essential to be flipping a metabolic switch from storage mode to export mode.

Mark 10:24

That's precisely what it's doing. It drops. Which brings us to the clinical outcomes regarding pre-pre-diabetes for reversal. This is whether the numbers get really incredible.

Rachel 10:44

Right, because these participants came in with pre-diabetes.

Mark 10:47

They did. And the difference in clinical resolution was stark. Following the matched 10% weight loss intervention, 50% of the participants in the ketogenic arm no longer met the clinical criteria for pre-diabetes.

Rachel 11:02

Half of them. Just completely reversed it.

Mark 11:04

Half.

Rachel 11:11

Wait, only seven percent for the planet forward group?

Mark 11:13

Just seven percent.

Rachel 11:14

A 52% reversal rate versus a 7% reversal rate, despite a dynamical weight loss, is a massive delta.

Mark 11:21

It is undeniable. The Kidogo group also demonstrated superior reductions into 24-hour continuous glucose

Prediabetes Reversal And CGM Data

Mark 11:28

profiles.

Rachel 11:28

Okay, well let's talk about that continuous monitoring, because most people just go to their doctor for fasting glucose diagonal sear and assuming fine. Is that not enough?

Mark 11:37

A standard fasting glucose test is really just a morning snapshot. It completely misses the area under the curves where glucose is an insult demand throughout the rest of the day. Exactly. A fasting panel fails to take temperature both print and okay. But following a mixed meal, one might maintain stable glucosinetics, while the other experiences significant both cranial excursions, requiring the pancreatic beta cells to secrete massive compensatory surges of an insulin, just to return to baseline.

Rachel 12:14

Which means that their beta cells are under constant exhausting stress.

Mark 12:18

Over time, yes. That chronic secretory demand leads to beta cell dysfunction and eventually failure.

Rachel 12:25

Which is just full-blown diabetes.

Mark 12:26

Exactly. By utilizing continuous glucose monitoring, the researchers couldn't perform that the ketodin diet didn't just improve the morning synaptic. It is significantly lowered at the 24-hour glycemic burden.

Rachel 12:36

Because they simply weren't eating the carbs that cause the spikes. Okay, so just to read back where we are. We have skeletal muscle improving uniformly across all diets, but the clearing at cock fat and restoring insulin sensitivity at a vastly accelerated rated keto. Which subsequently relieves the burden on the pancreas. But I mean, we have to address the obvious physiological counterargument here.

Cholesterol, ApoB, And Context

Rachel 13:12

Cholesterol.

Mark 13:20

Of course it does.

Rachel 13:21

I mean, substituting that volume of carbohydrates with fat should theoretically drive athroydynamic markers through the roof of the case.

Mark 13:27

That is a standard assumption, yes. But did it surprisingly, no. When analyzing the aggregate data of this specific trial, the ketodenic cohort did not exhibit a statistically significant group level elevation in LDL cholesterol or APOB.

Rachel 13:51

Okay, APO B finding is particularly relevant here.

Mark 14:01

Yes, APOB is crucial.

Rachel 14:02

I looked at it this way, tell me if this makes sense. Think of standard LDDL as the total volume of garbage you need to remove from a building.

Mark 14:10

Okay, I like this.

Rachel 14:11

And an Apo B is the actual number of individual trash bags you were using to carry it out. You could have the exact same total volume of trash, but if it can be packed into a hundred tiny bags instead of ten large ones, the sheer number of bags increases the statistical probability that one of them is going to get snagged, rip open, and causes a mess in the hallway.

Mark 14:32

Or in this case, penetrate the arterial wall and initiate atherosclerosis.

Rachel 14:37

Exactly.

Mark 14:38

But it is a highly accurate way to conceptualize his particle number versus his colour concentration.

Rachel 14:43

Thanks. So the fact that the AP didn't spike is huge.

Mark 14:47

It is. The fact that the average A B particle concentration did not significantly insulate on a diet consisting of 73% fat suggests that in this specific context, the libid burden remained relatively stable.

Rachel 14:59

But in the real world, outside of a strictly controlled feeding environment where everything is weighted and measured, we would have to look at the sustainability and the long-term lipid kinetics.

Mark 15:09

Absolutely.

Rachel 15:10

Is it realistic to maintain a 73% fat intake without eventually driving those lipid numbers off a cliff? Because I mean this trial has a very specific temporal context.

Mark 15:22

That is the vital caveat here. If we can connect this to the bigger picture, we must heavily contextualize these lipid findings.

Rachel 15:29

Okay, context. Laid out.

Mark 15:31

First, this trial kept her data in a phase of active dynamic weight loss.

Rachel 15:35

Right, because they were actively losing that 10%.

Mark 15:38

Exactly. Lividables behaves very differently during active polysis and weight reduction than it does during eupaloric weight mini minutes.

Rachel 15:46

So when the weight stabilizes, things change.

Mark 15:48

Drastically. None at all. We cannot ignore the weight of evidence from trials like pre-dependent.

Rachel 16:16

Right. The big medical training in diet study.

Mark 16:18

Yes. That study followed over 7,400 high-risk individuals over nearly five years and demonstrated hard incontrovertible reductions in major cardiovascular events using a medical training diet supplemented with extra virgin olive oil or nuts.

Rachel 16:34

So we are saying keto is suddenly the universally superior diet for heart health.

Mark 16:38

No, absolutely none. The Selma metabolism study we were discussing today is a short-term mechanistic trial focused on intermediate metabolic markers, not long-term cardiovascular mortality.

Rachel 16:49

So what does this all mean? Well, we have keto acting as a highly efficient tool for hepatic fat clearance and glycemic control. A Mediterranean diet holding the crown for longitudinal cardiovascular outcomes.

Mark 17:01

Exactly. It's better using the right tool for right shop.

Rachel 17:03

Furthermore, the biological variance among individuals is just huge. I mean, just because the group averaged for APOD didn't spike a keto armor doesn't mean a specific individual won't experience a severe athrogenic response to saturated fat.

Mark 17:16

Oh, the individual variability is immense. One patient might adopt severe carbohydrate restriction to resolve their hyperinsulin anemia, and then see their triglyceride to HDL ratio optimized beautifully. Right. But another patient might adopt the exact same protocol and experience a dangerous explosion in their API particle count. You just cannot rely on group averages to dictate individual clinical decisions.

Lab Markers For Personalized Nutrition

Rachel 17:42

And if individual variants is that high standard metabolic panels, a quick and annual physical really aren't going to cut it for someone attempting to use nutrition as a targeted metabolic preparation.

Mark 17:53

Not even close.

Rachel 17:53

Tracking your weight on a bathroom scale gives you absolutely zero insight into your hepatic sensitivity or your AB trajectory.

Mark 18:00

Rhodoline on a scale is fundamentally inadequate. To safely utilize these dietary interventions, you really have to detract the airline biochemistry.

Rachel 18:08

You have to look under the hood.

Mark 18:10

You need comprehensive metabolic and cardiometabolic panels to establish such a baseline and monitor the physiological response.

Rachel 18:18

We aren't just talking about basic lipid panels where the tell your total cholesterol is a little high. We are looking at specific markers to evaluate the organs we've been discussing today.

Mark 18:28

For evaluating lasemic control beyond the fasting state, fasting insulin is critical. And for cardiovascular risk assessment, quantifying apope is simply non-negotiable when heavily manipulating dietary fats.

Rachel 18:43

What about the liver? So that was the star of the show today.

Mark 18:46

For the liver, standard hepatic enzyme acids like AST and ALT are useful, but they lack sensitivity. They can actually appear completely normal, even as non-alcoholic fatty liver disease is actively progressive.

Rachel 18:58

Which is terrifying.

Mark 18:59

It is, which is why the FIB4 index is becoming a standard tool.

Rachel 19:03

The FIB4 index, I've heard of that. It isn't just looking at a single enzyme, right?

Mark 19:07

Right, it's its algorithm. It factors in your age, your AST and ALT levels, and your platelet count to generate a highly predictive score, estimating your risk for advanced liver fibrosis.

Rachel 19:18

So it's much more holistic.

Mark 19:19

Utilizing those specific diagnostic indices allows a patient to move beyond blind dietary adherence and actually measure the tissue-specific efficacy of the interventin.

Rachel 19:31

And accessing that level of diagnostic clarity is actually becoming much more streamlined these days. I know the team at Quick Lab Mobile in Miami, who provided the analysis of this study for us, they actually facilitate at-home blood collection for these exact cardiometabolic panels.

Mark 19:46

Which is so convenient.

Rachel 19:48

It really is. It completely removes the friction of clinical waiting rooms and provides the precise data required. You know, the APOV, the fastest insulin, the markers for the FIV4 calculation, so you can monitor how your internal organs are actually responding to your macro split.

Mark 20:02

Because collecting that robust baseline data, implementing a dietary intervention, and then conducting follow-up of assays, well, that is the very definition of evidence-based personal medicine.

Medication Risks And Ketoacidosis Warning

Rachel 20:12

But, and this is a big but, deploying food as a powerful metabolic intervention carries the exact same clinical risks as deploying pharmacology.

Mark 20:21

Oh, without a doubt.

Rachel 20:22

There are serious potentially life-threatening contraindications to aggressive carbohydrate restriction that we absolutely have to outline before we wrap up.

Mark 20:31

Yes. Any patient currently prescribed antihypertensive medications or utilizing insulin or sulfonalureas for the management of type 2 diabetes, they must exercise extreme caution. Because fixing the metabolism while still taking the drugs can crash the system in rapidly depleting hepatic glycogen in stores and lowering systemic insulin levels via carbohydrate restriction can induce acute, dangerous drops in both blood pressure and blood glucose.

Rachel 20:58

You could pass out, or worse.

Mark 20:59

Pharmacological dosages often require immediate preemptive titration by a physician. You have to adjust the meds as the diet takes effect.

Rachel 21:07

The interaction with SGLT2 inhibitors is particularly dangerous from what I understand. These are medications like empaglyflosin or dupoglyflosin, which is widely prescribed right now.

Mark 21:17

Extremely common. And yes, very dangerous in this context. SGLT2 inhibitors function by altering renal thresholds, forcing the kidneys to excrete excess glucose through the urine.

Rachel 21:28

So you just pee out the sugar?

Mark 21:30

Basically, yes. This process artificially lowers blood glucose and circulating insulin.

Rachel 21:35

Okay, so what happens if you combine that with a keto diet?

Mark 21:38

If you compound that pharmacological effect with a ketogenic diet that already restricts incoming dietary glucose, you induce a state of profoundly low insulin and highly elevated glucagon.

Rachel 21:49

Oh, that glucagon ratio again.

Mark 21:51

Right. But in this extreme state, the liver interprets this specific endocrine signal as pure starvation. It panics, essentially, and begins producing ketone in the bodies at an uncontrollable rate.

Rachel 22:02

Uncontrollable like toxic levels.

Mark 22:04

Yes. It leads to glycemic diabetic ketoacidosis. That is a severe, life-threatening metabolic emergency. The blood turns acidic. Wow. The FDA actually specifically warns again it's combining severe carbohydrate restriction with this class of drugs.

Rachel 22:18

It is a stark reminder of the potency of the pathways we are manipulating here. You are literally reprogramming your body's primary fuel substrate. Doing that without medical oversight while on specific pharmaceuticals is incredibly reckless.

Mark 22:33

The clinical oversight is simply mandatory. I cannot stress that enough.

The Big Takeaway Plus Brain Tease

Rachel 22:37

Well, to synthesize the core mechanics we've unpacked today for everyone listening, the fundamental premise of the diet wars is lacking crucial biological nuance. The thermodynamic of weight loss absolutely matters. If you are carrying excess adiposity, achieving a caloric deficit to reduce that mass will uniformly improve skeletal muscle insulin sensitivity, regardless of whether you restrict fats or you restrict carbohydrates.

Mark 23:02

The muscle just wants the weight gone.

Rachel 23:04

Exactly. But macronutrients are not just fuel, they are biological signaling molecules that act as highly specific levers for specific organs.

Mark 23:12

Which is the real takeaway here.

Rachel 23:14

Right. Carbohydrate restriction isn't merely a mechanism for caloric deficit. It is an endocrine liver that suppresses insulin, elevates glucagon, and biochemically commands the liver to halt lipogenesis and begin oxidizing stored triglycerides. Let's hear it.

Mark 23:33

We have spent this entire analysis looking at how these specific macronutrient ratios dictate the metabolic fate of the liver and the pancreas, right? But if restricting carbohydrates and forcing the hepatic production of ketone bodies can fundamentally alter the energy substrate and signaling pathways in those peripheral organs, what happens when we apply that exact same metabolic lever to the brain?

Nicolette 23:56

Oh well.

Mark 23:57

If ketones can bypass impaired insulin receptors in hepatic tissue, could this same nutritional intervention bypass the cerebral glucose hypometabolism we see in neurodegenerative conditions like Alzheimer's?

Rachel 24:09

Now that is a paradigm shift. Eating for your specific organs, maybe even your brain, instead of just eating for your waste designs. Well, that is all the time we have for today. Thank you so much for joining us on this deep dive, and we'll see you next time.

Closing And Where To Learn More

Nicolette 24:27

Thanks for tuning into the health pulse. If you found this episode helpful, don't forget to subscribe and share it with someone who might benefit. For more health insights and diagnostics, visit us online at www.quicklabmobile.com. Stay informed, stay healthy, and we'll catch you in the next episode.